Magnetic Resonance Cholangiopancreatography Severity Predicts Disease Outcomes in Pediatric Primary Sclerosing Cholangitis: A Reliability and Validity Study
Kedar Patil, Amanda Ricciuto, Alaa Alsharief, Jehan Al‐Rayahi, Afsaneh Amirabadi, Peter C. Church, Binita M. Kamath, Mary‐Louise C. Greer – 6 December 2019 – Magnetic resonance cholangiopancreatography (MRCP) has not been assessed as a surrogate biomarker in pediatrics. We aimed to determine the inter‐rater reliability, prognostic utility, and construct validity of the modified Majoie endoscopic retrograde cholangiopancreatography classification applied to MRCP in a pediatric primary sclerosing cholangitis (PSC) cohort.